7OHMZ Gummies: The Custom Gummy Molds We Made Before FDA Enforcement

Before federal regulators publicly targeted 7OHMZ’s 7-hydroxymitragynine gummies, Gummy Molds designed and prototyped custom branded gummy molds for Thang Botanicals’ 7OHMZ product line. The project moved from logo geometry to full production layouts and real silicone prototype samples. Months later, FDA issued a warning letter naming Thang Botanicals d/b/a 7OHMZ and specifically identifying its Strawberry Acai 7-Hydroxymitragynine Gummies.

This article documents the mold-development side of that project and explains what later changed from a regulatory standpoint. It is not a product endorsement, and Gummy Molds did not formulate the edible or determine the legality of its ingredients.

What Were 7OHMZ Gummies?

7OHMZ gummies were branded 7-hydroxymitragynine edible products sold by Thang Botanicals under the 7OHMZ name. FDA’s June 25, 2025 warning letter specifically identified a 7OHMZ 7-Hydroxymitragynine Gummies product in Strawberry Acai flavor and stated that its labeling declared the presence of 7-OH.

FDA said the gummies were a conventional food containing added 7-OH or kratom extract and concluded that the product contained an unsafe food additive. The agency stated that introducing adulterated food into interstate commerce is prohibited under the Federal Food, Drug, and Cosmetic Act.

Read the full FDA warning letter to Thang Botanicals d/b/a 7OHMZ.

7OHMZ Gummies: Historical Product Snapshot

Our Custom Gummy Mold Project for 7OHMZ

Before that public FDA enforcement action, Gummy Molds worked on custom branded gummy tooling for the 7OHMZ product line. The project included two related round-logo concepts: a stylized 7OHMZ mark and an omega-style symbol used as a second branded cavity design.

The mold renderings, production layouts and silicone prototype photographs shown below are original Gummy Molds project materials from our work on the 7OHMZ tooling. They document the progression from logo geometry to physical production samples.

The development process followed the same basic engineering path used for other proprietary gummy shapes:

• convert the supplied visual identity into manufacturable 3D geometry;
• check detail depth, wall thickness, draft and demolding behavior;
• build production cavity layouts;
• produce prototype silicone samples; and
• evaluate whether the finished cavity design remains readable at gummy scale.

The objective was purely tooling and manufacturing: create a branded gummy shape that could be produced consistently in silicone molds.

Initial 3D Logo Concepts

The first step was converting the brand marks into three-dimensional gummy geometry. Flat logos often contain linework that looks clear on packaging but becomes too thin or fragile when translated into an edible.

For the 7OHMZ project, the raised logo elements had to remain recognizable while still allowing the finished gummy to release cleanly from flexible silicone.

A second omega-style mark was also modeled as a round branded gummy piece.

Turning a Branded Gummy Into a Production Mold

Once the individual piece geometry is approved, the engineering problem changes from a single gummy to an entire production sheet. Cavity pitch, edge clearance, mold dimensions, support, and filling method all matter.

A visually attractive single cavity can still create a poor commercial mold if the layout wastes space, the sheet flexes excessively during depositing, or the cavities are arranged in a pattern that does not match the production method.

For this project, the branded round pieces were repeated across dense production layouts designed to maximize output while preserving consistent spacing. Manufacturers comparing standard production tooling can browse our commercial gummy molds, and our guide to how many gummy molds are needed for commercial production explains how mold count, cycle time and throughput fit together.

Prototype Silicone Samples

The project progressed beyond CAD and layout work into physical silicone prototypes. Prototype molds are useful because they reveal issues that are difficult to judge from a screen alone: how the silicone flexes, how clearly the cavity detail reads in real material, and whether the proportions still make sense at production scale.

The prototype samples shown here were made before the later FDA warning involving 7OHMZ’s 7-hydroxymitragynine products.

What the 7OHMZ Gummies Looked Like

The omega-logo gummies shown below are isolated from historical product imagery so the finished branded shape can be seen without the surrounding packaging. They show how the raised omega mark remained legible on the sugared finished pieces.

For a branded gummy, this is the point where CAD has to prove itself in the real product. Raised or recessed marks must remain readable after depositing, setting, demolding and any finishing step such as sugar coating.

7OHMZ Regulatory Timeline

What Happened to 7OHMZ Gummies?

On June 25, 2025, FDA issued a warning letter to Thang Botanicals, Inc. d/b/a 7OHMZ. The letter addressed several products, including the Strawberry Acai 7OHMZ 7-Hydroxymitragynine Gummies.

FDA said there was no food-additive regulation authorizing 7-OH or kratom extract for use in conventional food and said it was not aware of a basis to consider those ingredients generally recognized as safe for that use. FDA therefore concluded that the gummies were adulterated because they contained an unsafe food additive.

The same warning letter also addressed 7OHMZ dietary-supplement products containing 7-OH and stated that available safety information was inadequate to provide reasonable assurance that the ingredient did not present a significant or unreasonable risk of illness or injury.

Did FDA “Ban” 7OHMZ Gummies?

The precise answer is more nuanced than saying FDA simply “banned” the brand.

FDA’s warning letter said the specific Strawberry Acai 7OHMZ gummies were adulterated conventional food because they contained an unsafe food additive, and that introduction or delivery of adulterated food into interstate commerce is prohibited. FDA also said 7-OH and kratom extract were not approved for use in conventional food.

That is different from saying FDA created a new nationwide controlled-substance ban on the date of the letter. Food-law enforcement and controlled-substance scheduling are separate legal frameworks.

Are 7OHMZ Gummies Still Sold?

As of September 30, 2026, at least one third-party retailer page for a 7OHMZ gummy SKU remained indexed and displayed a price and an Add to Cart option. Gummy Molds has not independently verified whether that listing is currently being fulfilled, whether inventory is actually available, or the present operating and distribution status of the 7OHMZ brand.

A current retail listing does not establish that a product is lawful. FDA states that added or enhanced 7-OH is not lawful as a dietary supplement and cannot lawfully be added to conventional foods, and federal and state requirements should be checked independently.

What Is 7-Hydroxymitragynine, or 7-OH?

7-hydroxymitragynine, often shortened to 7-OH, is an alkaloid associated with kratom. FDA has raised safety concerns about products containing added or enhanced levels of 7-OH and has described the compound as having opioid-like effects.

FDA’s warning letter noted concerns including adverse-event reports and the lack of an FDA evaluation establishing safe use for products containing 7-OH. FDA’s current consumer guidance recommends avoiding products containing added or enhanced 7-OH and states that these products have not been proven safe or effective for any use.

See FDA’s current consumer update on products containing 7-OH.

What Changed in 2026?

In July 2026, DEA published a notice of intent to temporarily place 7-hydroxymitragynine above a specified threshold into Schedule I of the Controlled Substances Act. The Federal Register document explicitly described the action as a proposed amendment and notice of intent.

That distinction matters. A notice of intent announces the agency’s plan to issue a temporary scheduling order; it is not the same thing as saying the final scheduling order had already taken effect.

HHS later extended the public-comment period on the proposed threshold through September 10, 2026. DEA’s July 2026 public statement says the controlled-substance restrictions apply once temporary scheduling orders take effect, which is why a notice of intent should not be described as if the final order were already effective.

Regulatory status last reviewed: September 30, 2026. Manufacturers should verify the current federal and state status directly from official sources before making legal or compliance decisions.

See the Federal Register notice concerning proposed temporary scheduling of 7-OH above a specified threshold.

Why This Project Is a Useful Regulatory Case Study

For Gummy Molds, the important lesson is not about promoting 7-OH. It is about how quickly the regulatory position surrounding a finished edible can become a major commercial issue even after packaging, branding and production tooling have already been developed.

A custom gummy mold manufacturer is responsible for the tooling it supplies. The finished-product manufacturer remains responsible for its ingredients, formulation, claims, labeling, licensing and legal compliance.

That distinction becomes especially important for products involving cannabis, hemp, kratom, novel ingredients, supplements or other categories where federal and state requirements can change or differ.

Custom Gummy Molds for Regulated Product Categories

Gummy Molds works with manufacturers that need proprietary shapes, logos and commercial cavity layouts. For custom branded projects, visit our Custom Gummy Mold page.

Manufacturers working in cannabis and adult-use edible categories can also browse our THC & Edible Gummy Molds collection. These mold categories relate to physical product design and manufacturing; they do not establish whether a particular ingredient or finished edible is lawful in a given jurisdiction.

For planning and engineering considerations, see our custom gummy mold cost guide and commercial gummy mold buyer’s guide.

For another first-party branded edible mold case study, see how we engineered the Toad Venom frog gummy mold for Super Chill Goods from artwork through finished gummy shape.

What Manufacturers Should Verify Before Launching a Regulated Gummy

• Whether the active or functional ingredient is permitted in the intended product category.
• Whether federal, state and local restrictions differ.
• Whether labeling, potency, testing or child-resistant packaging requirements apply.
• Whether marketing claims change the regulatory classification of the product.
• Whether the formulation has appropriate safety and compliance support.
• Whether a later change in law or agency enforcement position could affect existing inventory or tooling.

Tooling can be manufactured correctly while the finished product still faces a separate regulatory problem. Those are different parts of the manufacturing process and should be reviewed independently.

Frequently Asked Questions

What were 7OHMZ gummies?

7OHMZ gummies were branded 7-hydroxymitragynine edible products sold under the 7OHMZ name by Thang Botanicals. FDA’s June 2025 warning letter specifically identified Strawberry Acai 7OHMZ 7-Hydroxymitragynine Gummies.

What happened to 7OHMZ gummies?

FDA issued a June 25, 2025 warning letter to Thang Botanicals d/b/a 7OHMZ and concluded that the identified Strawberry Acai gummies were adulterated conventional food because they contained an unsafe food additive. FDA later publicly announced warning letters involving seven firms marketing products containing 7-OH.

Are 7OHMZ gummies illegal?

FDA states that added or enhanced 7-OH is not lawful as a dietary supplement and cannot lawfully be added to conventional foods. The exact legal status of possession, sale or distribution can also depend on controlled-substance rules and state law, so current jurisdiction-specific requirements should be checked separately.

Are 7OHMZ gummies still sold?

As of September 30, 2026, at least one third-party retailer page still appeared in search results for the gummy SKU and displayed a price and Add to Cart option. Gummy Molds has not independently verified actual inventory, fulfillment, or the current operating and distribution status of the brand. A retail listing does not establish regulatory compliance.

Why did FDA warn 7OHMZ?

FDA said the Strawberry Acai gummies contained added 7-OH or kratom extract that was not approved for use in conventional food and did not meet the requirements for lawful food-additive use. The warning letter also addressed separate 7OHMZ products marketed as dietary supplements.

What is 7-hydroxymitragynine, or 7-OH?

7-OH is an alkaloid associated with kratom. FDA distinguishes naturally occurring trace amounts in kratom from products containing added or enhanced levels of 7-OH and has warned about the latter because of safety concerns and opioid-like effects.

Is 7-OH a Schedule I controlled substance?

DEA published a July 2026 notice of intent to temporarily place 7-OH above a specified threshold into Schedule I. DEA stated that covered substances become subject to CSA restrictions once temporary scheduling orders take effect. Because the process is time-sensitive, current status should be verified from DEA and the Federal Register.

Did Gummy Molds manufacture the 7OHMZ gummies?

Gummy Molds designed and produced custom gummy mold tooling and physical silicone prototypes for the project. We did not formulate the finished edible, manufacture its active ingredients or make potency or efficacy claims.

Who made the custom 7OHMZ gummy molds?

Gummy Molds developed the branded cavity geometry, production layouts and silicone prototypes shown in this article for the 7OHMZ project.

Can a logo be turned into a commercial gummy mold?

Usually, yes. A logo may need engineering adjustments so fine features remain readable, the gummy demolds cleanly, and the cavity layout works with the intended production method.

Can Gummy Molds create molds for regulated product categories?

We can engineer physical gummy shapes and silicone tooling for manufacturers. The finished-product manufacturer is responsible for confirming that its ingredients, formulation, claims, labeling and sale comply with applicable laws and regulations.

The Bottom Line

The 7OHMZ project is a useful example of how product design and regulatory compliance can follow very different timelines. Gummy Molds designed branded gummy tooling and physical prototypes for Thang Botanicals before FDA later issued a warning letter specifically addressing 7OHMZ’s 7-hydroxymitragynine gummies.

The mold-development work remains a real manufacturing case study. The later FDA action is also a reminder that companies producing gummies in regulated or emerging categories need to treat ingredient compliance, formulation, labeling and legal review as separate from the tooling itself.

Official Sources

• FDA — Warning Letter to Thang Botanicals, Inc. d/b/a 7OHMZ, June 25, 2025
• FDA — Warning Letters for Products Containing 7-Hydroxymitragynine, July 15, 2025
• FDA — Products Containing 7-OH Can Cause Serious Harm
• DEA — Notice of Intent to Temporarily Schedule 7-OH and Related Substances, July 1, 2026
• Federal Register — Notice of Intent Concerning 7-Hydroxymitragynine Above a Specified Threshold

This article is for informational purposes and documents a historical custom mold project. It is not legal advice, a statement that any current product is lawful, or an endorsement of 7-OH products. Regulatory requirements can change and may vary by jurisdiction.